The SPARCL trial: Atorvastatin reduces risk of stroke in patients with recent stroke or transient ischemic attack [Classics Series]
Image: CC/L. academia 1. In patients with recent stroke or TIA, high-dose atorvastatin significantly reduces the risk of fatal stroke compared ...